跳至主要内容
临床试验/TCTR20171115001
TCTR20171115001已完成4 期

Analgesic Efficacy of Intravenous Nefopam after Spine Surgery: A Randomized, Double-Blind, Placebo-Controlled Trial

Department of Medical Services0 个研究点目标入组 96 人开始时间: 2017年11月15日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
96

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 0 N/A (No limit)(—)
性别
All

入选标准

  • 1. Age ≥ 18 years
  • 2. Scheduled for lumbosarcral spine surgery under general anesthesia
  • 3. ASA physical status I - III
  • 4. Operation time 4 - 6 hours
  • 5. Not known allergy to morphine and nefopam

排除标准

  • 1. Current nefopam use within 24 hours prior to study
  • 2. Previous history of cardiovascular disease
  • 3. Previous history of epilepsy
  • 4. Previous history of liver disease
  • 5. Previous history of chronic opioids therapy > 2 weeks
  • 6. Previous history of chronic Monoamine oxidase inhibitors (MAOIs) therapy > 2 weeks
  • 7. Unable to use patient controlled analgesia (PCA) device
  • 8. Creatinine clearance < 30 mL/min (calculated by the Cockcroft-Gault equation)

研究者

相似试验